ForgeBio
Startup
Stability, Expression, Scale-Up: Engineering Better Vaccines and Biologics
ForgeBio provides AI-based protein engineering solutions to accelerate the development of efficacious vaccines and therapeutic proteins. We specialize in improving vaccine antigens by enhancing stability, boosting expression levels, and enabling smoother scale-up in both upstream and downstream processing.
With deep expertise in viral fusion and attachment proteins (e.g. RSV, HMPV, Influenza, Paramyxovirus, Coronavirus), combined with cutting-edge physics-based modeling and advanced AI tools, ForgeBio designs and optimizes proteins tailored to our clients’ needs. Our approach supports both biotech and pharmaceutical partners in creating superior vaccine components, refining existing protein leads, and unlocking new opportunities in biologics development.
ForgeBio offers both consultancy and fee-for-service projects in vaccine development for partners of all sizes. Our unique experience combined with state-of-the-art tools allows us to deliver practical, science-driven solutions while generating novel intellectual property.
Our mission is to empower our clients with innovative protein engineering strategies that transform early concepts into scalable, impactful healthcare products.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events